Related Experiment Video
Updated: Jan 20, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Risk Factors for Doxorubicin-Induced Serious Hyperglycaemia-Related Adverse Drug Reactions
Jincheng Yang1, Yu Wang2, Kang Liu2
1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Yangjc@cicams.ac.cn.
Doxorubicin can cause serious hyperglycemia-related adverse drug reactions (HG-ADRs). Older males are at higher risk for severe outcomes from these reactions, highlighting the importance of age and gender in patient monitoring.
Area of Science:
- Oncology
- Pharmacovigilance
- Endocrinology
Background:
- Hyperglycemia is linked to increased cancer mortality.
- Doxorubicin, used for pancreatic cancer, is a significant inducer of hyperglycemia-related adverse drug reactions (HG-ADRs).
Purpose of the Study:
- To analyze risk factors for serious doxorubicin-induced HG-ADRs.
- To identify patient demographics associated with severe outcomes.
Main Methods:
- Analysis of 558 individual case safety reports of doxorubicin-induced HG-ADRs from VigiBase (2000-2017).
- Bivariate correlation and logistic regression used to assess factors influencing outcome seriousness.
- Age stratification into five groups.
Main Results:
- 71.1% of cases had serious outcomes, and 10.9% resulted in death.
- Age and gender were significantly correlated with outcome seriousness (P < 0.01).
- Factors like year reported, ADR duration, latency, treatment duration, and dosage did not correlate with outcome seriousness.
Conclusions:
- Age and gender are significant risk factors for serious doxorubicin-induced HG-ADRs.
- Male patients and older individuals face a higher likelihood of severe outcomes.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Allergic Drug Reactions
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...

